Foreword |
|
xi | |
|
Acknowledgments |
|
xiii | |
Introduction: Careers Set Questions |
|
1 | (9) |
|
|
Part 1 Addiction Careers and Administration at a High Level |
|
|
|
1 Conversation with Robert L. DuPont, MD., President of the Institute for Behavior and Health, Inc. Rockville, MD, USA and Clinical Professor of Psychiatry, Georgetown University School of Medicine, Washington, DC, USA |
|
|
10 | (6) |
|
|
2 Conversation with Richard Fuller, MD, Retired |
|
|
16 | (7) |
|
|
3 Conversation with Cees Goos, MD., Consultant, Anton Proksch Institute, Vienna, Austria |
|
|
23 | (7) |
|
|
4 Conversation with Enoch Gordis, MD., Retired |
|
|
30 | (7) |
|
|
5 Conversation with Leland H. Towle, SM (MIT), Retired |
|
|
37 | (7) |
|
|
6 Commentary by Peter Anderson, MD, PhD, MPH., Professor, Alcohol and Health, Faculty of Health Medicine and Life Sciences, Maastricht, Netherlands |
|
|
44 | (8) |
|
Part 2 Laboratory Life: The Making of Addiction Pharmacology and Behavioural Pharmacology |
|
|
|
7 Conversation with Joseph V. Brady, PhD., Formerly Director, Behavioral Biology Research Center, John Hopkins Medicine, Baltimore, MD, USA (Deceased 29 July 2011) |
|
|
52 | (6) |
|
|
8 Conversation with E. A. Carlini, MD., Professor, Federal University of Sao Paulo, Sao Paulo, Brazil |
|
|
58 | (6) |
|
Joao Carlos Dias da Silva |
|
|
9 Conversation with Lou Harris, PhD., Harvey Haag Professor, Department of Pharmacology and Toxicology, Medical College of Virginia, Virginia Commonwealth University, Richmond VA, USA |
|
|
64 | (7) |
|
|
10 Conversation with Conan Kornetsky, PhD., Professor, Departments of Psychiatry and Pharmacology, Boston University School of Medicine, Boston, Massachusetts, USA |
|
|
71 | (8) |
|
|
11 Conversation with Michael Kuhar, PhD., Chandler Professor of Neuropharmacology, Georgia Research Alliance Eminent Scholar, Yerkes/Emory University, Atlanta GA, USA |
|
|
79 | (7) |
|
|
12 Conversation with Malcolm H. Lader, MD., PhD., FMedSci., Emeritus Professor of Clinical Psychopharmacology, Institute of Psychiatry, Kings College London, UK |
|
|
86 | (7) |
|
|
13 Conversation with Raphael Mechoulam, PhD., Emeritus Professor, Hebrew University, Institute for Drug Research, Medical Faculty, Institute for Drug Research, Ein Kerem Campus, Jerusalem, Israel |
|
|
93 | (7) |
|
|
14 Conversation with Charles R. Schuster, PhD, Formerly Distinguished Professor Emeritus, Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine USA (Deceased 21 February 2011) |
|
|
100 | (7) |
|
|
15 Conversation with Tomoji Yanagita, MD., Professor and Director of the Central Laboratory for Experimental Animals, Kawasaki, Japan |
|
|
107 | (7) |
|
|
16 Commentary by Jerome H. Jaffe, MD., Clinical Professor, Department of Psychiatry, Division of Alcohol and Drug Abuse, University of Maryland School of Medicine, Baltimore, Maryland, USA |
|
|
114 | (12) |
|
Part 3 Clinicians and Clinical Scientists |
|
|
|
17 Conversation with Timothy Cook, MA, Formerly Director, London and City Parochial Charities, London, UK |
|
|
126 | (7) |
|
|
18 Conversation with Hamid Ghodse, MD., PhD., BSc., Emeritus Professor of Psychiatry and International Drug Policy and Director, International Centre for Drug Policy, St George's University of London, London, UK |
|
|
133 | (7) |
|
|
19 Conversation with Nick Heather, PhD., Emeritus Professor of Alcohol and Other Drug Studies, Department of Psychology, School of Life Sciences, Northumbria University, Newcastle upon Tyne, UK |
|
|
140 | (7) |
|
|
20 Conversation with Martin Jarvis, PhD., Emeritus Professor of Health Psychology, Department of Epidemiology & Public Health, University College London, London, UK |
|
|
147 | (7) |
|
|
21 Conversation with Jim Orford, PhD., Emeritus Professor, School of Psychology, University of Birmingham, Edgbaston, Birmingham, UK |
|
|
154 | (8) |
|
|
22 Conversation with Shanthi Ranganathan, MD. Founder and Hon Secretary, T.T. Ranganathan Clinical Research Foundation, TTK Hospital, Chennai, India |
|
|
162 | (6) |
|
|
23 Conversation with Bruce Ritson, MD, Formerly Consultant and Hon Senior Lecturer, Royal Edinburgh Hospital, UK |
|
|
168 | (8) |
|
|
24 Conversation with Michael A. H. Russell, MA, MAppSci, PhD. Formerly Professor of Addiction, Institute of Psychiatry, London, UK. (Deceased 16 July 2009) |
|
|
176 | (7) |
|
|
25 Conversation with Hiroshi Suwaki, MD., Consultant, Honorary Professor of Kagawa University, Incorporated Medical Institution, Sankou Psychiatric Hospital, Kagawa, Japan |
|
|
183 | (8) |
|
|
26 Conversation with Ambros Uchtenhagen, MD., PhD., Emeritus Professor of Social Psychiatry at Zurich University, Chair, Addiction and Public Health Research Foundation at Zurich University, Research Institute for Public Health and Addiction, Zurich, Switzerland |
|
|
191 | (7) |
|
|
27 Commentary by Ilana Crome, MD, FRCPsych, Formerly Professor of Addiction Psychiatry and Academic Director of Psychiatry, Keele University Medical School, Consultant, Addiction Psychiatrist, South Staffordshire and Shropshire Healthcare NHS Foundation Trust, St George's Hospital, Stafford, UK |
|
|
198 | (10) |
|
Part 4 Careers in Social Science and Epidemiology |
|
|
|
28 Conversation with M. Douglas Anglin, PhD., Professor in Residence, Associate Director, Integrated Substance Abuse Programs, University of California, Los Angeles, California, USA |
|
|
208 | (8) |
|
|
29 Conversation with Walter Clark, PhD, Senior Scientist, Alcohol Research Group, Berkeley, California, USA |
|
|
216 | (6) |
|
|
30 Conversation with Joseph Gusfield, PhD., Chair of the Sociology Department, University of California, La Jolla, California, USA |
|
|
222 | (7) |
|
|
31 Conversation with Ragnar Hauge, Cand.Jur., former Director of the National Institute of Alcohol and Drug Research, Oslo, Norway |
|
|
229 | (7) |
|
|
32 Conversation with Harold Holder, PhD, Senior Scientist Emeritus, Prevention Research Center, Pacific Institute for Research and Evaluation, El Cerrito, California, USA |
|
|
236 | (7) |
|
|
33 Conversation with Rudolf Moos, PhD., Professor Emeritus, Department of Psychiatry, Stanford University, Palo Alto, California, USA |
|
|
243 | (8) |
|
|
34 Conversation with Juha Partanen, PhD, Formerly Professor and Director, Social Research Institute for Alcohol Studies, Helsinki, Finland |
|
|
251 | (7) |
|
|
35 Commentary by Kerstin Stenius, PhD., Editor-in-Chief, Nordisk Alkohol-och Narkotikatidskrift (Nordic Studies on Alcohol and Drugs), Helsinki, Finland; Professor, Centre for Social Research on Alcohol and Drugs, Stockholm University, Stockholm, Sweden |
|
|
258 | (8) |
|
Part 5 Clinicians and Clinical Research: American Contributions |
|
|
|
36 Conversation with Sheila Blume, MD., Former Medical Director, Addiction and Compulsive Gambling Services, South Oaks Hospital, Amityville, New York, USA |
|
|
266 | (7) |
|
|
37 Conversation with Roger E. Meyer, MD., Professor of Psychiatry, Penn State University Hershey Medical Center, Hershey, PA, USA |
|
|
273 | (8) |
|
|
38 Conversation with William R. Miller, PhD., Emeritus Distinguished Professor of Psychology and Psychiatry, University of New Mexico, New Mexico, USA |
|
|
281 | (6) |
|
|
39 Conversation with George Vaillant, MD., Professor of Psychiatry, Harvard Study of Adult Development, Boston, Massachusetts, USA |
|
|
287 | (7) |
|
|
|
40 Conversation with William L. White, MA., Senior Research Consultant, Chestnut Health Systems, Lighthouse Institute, Illinois, USA |
|
|
294 | (7) |
|
|
41 Commentary by Jonathan Chick, MA (Cantab), MPhil, DSc, FRCPE, FRCPsych., Honorary Professor, School of Health Sciences, Queen Margaret University, Edinburgh, United Kingdom |
|
|
301 | (6) |
|
Addiction Careers: Catalysts for an Interdisciplinary Field |
|
|
|
42 Thomas F. Babor, PhD, MPH. Associate Editor-in-Chief, Addiction; Regional Editor for Addiction, US Office; Professor and Chairman, Department of Community Medicine & Health Care, University of Connecticut School of Medicine, Farmington, Connecticut, USA |
|
|
307 | (12) |
Index |
|
319 | |